Galibier Capital Management Ltd. Merck & Co., Inc. Transaction History

Galibier Capital Management Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$69.84 - $81.59 $1.18 Million - $1.38 Million	-16,868 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$69.58 - $79.36 $119,468 - $136,261	-1,717 Reduced 9.24%	16,868 $1.4 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $1.21 Million - $1.41 Million	18,585 New	18,585 $1.42 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Galibier Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Galibier Capital Management Ltd. with notifications on news.